185 related articles for article (PubMed ID: 17473010)
21. An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode.
Larsen NA; Nash TJ; Morningstar M; Shapiro AB; Joubran C; Blackett CJ; Patten AD; Boriack-Sjodin PA; Doig P
Biochem J; 2012 Sep; 446(3):405-13. PubMed ID: 22721802
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU.
Li Y; Zhou Y; Ma Y; Li X
Carbohydr Res; 2011 Sep; 346(13):1714-20. PubMed ID: 21704310
[TBL] [Abstract][Full Text] [Related]
23. Unique C-terminal extension and interactome of Mycobacterium tuberculosis GlmU impacts it's in vivo function and the survival of pathogen.
Agarwal M; Soni V; Kumar S; Singha B; Nandicoori VK
Biochem J; 2021 Jun; 478(11):2081-2099. PubMed ID: 33955473
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the bifunctional N-acetylglucosamine 1-phosphate uridyltransferase from Escherichia coli: a paradigm for the related pyrophosphorylase superfamily.
Brown K; Pompeo F; Dixon S; Mengin-Lecreulx D; Cambillau C; Bourne Y
EMBO J; 1999 Aug; 18(15):4096-107. PubMed ID: 10428949
[TBL] [Abstract][Full Text] [Related]
25. Chemoenzymatic synthesis of uridine diphosphate-GlcNAc and uridine diphosphate-GalNAc analogs for the preparation of unnatural glycosaminoglycans.
Masuko S; Bera S; Green DE; Weïwer M; Liu J; DeAngelis PL; Linhardt RJ
J Org Chem; 2012 Feb; 77(3):1449-56. PubMed ID: 22239739
[TBL] [Abstract][Full Text] [Related]
26. Nucleotide substrate recognition by UDP-N-acetylglucosamine acyltransferase (LpxA) in the first step of lipid A biosynthesis.
Ulaganathan V; Buetow L; Hunter WN
J Mol Biol; 2007 Jun; 369(2):305-12. PubMed ID: 17434525
[TBL] [Abstract][Full Text] [Related]
27. Aminoglycoside 2'-N-acetyltransferase from Mycobacterium tuberculosis in complex with coenzyme A and aminoglycoside substrates.
Vetting MW; Hegde SS; Javid-Majd F; Blanchard JS; Roderick SL
Nat Struct Biol; 2002 Sep; 9(9):653-8. PubMed ID: 12161746
[TBL] [Abstract][Full Text] [Related]
28. GlmU (N-acetylglucosamine-1-phosphate uridyltransferase) bound to three magnesium ions and ATP at the active site.
Vithani N; Bais V; Prakash B
Acta Crystallogr F Struct Biol Commun; 2014 Jun; 70(Pt 6):703-8. PubMed ID: 24915076
[TBL] [Abstract][Full Text] [Related]
29. Crystal structures identify an atypical two-metal-ion mechanism for uridyltransfer in GlmU: its significance to sugar nucleotidyl transferases.
Jagtap PK; Verma SK; Vithani N; Bais VS; Prakash B
J Mol Biol; 2013 May; 425(10):1745-59. PubMed ID: 23485416
[TBL] [Abstract][Full Text] [Related]
30. The crystal and solution studies of glucosamine-6-phosphate synthase from Candida albicans.
Raczynska J; Olchowy J; Konariev PV; Svergun DI; Milewski S; Rypniewski W
J Mol Biol; 2007 Sep; 372(3):672-88. PubMed ID: 17681543
[TBL] [Abstract][Full Text] [Related]
31. Structure of N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Mycobacterium tuberculosis in a cubic space group.
Verma SK; Jaiswal M; Kumar N; Parikh A; Nandicoori VK; Prakash B
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 May; 65(Pt 5):435-9. PubMed ID: 19407371
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase.
Williams AH; Raetz CR
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13543-50. PubMed ID: 17698807
[TBL] [Abstract][Full Text] [Related]
33. Probing the role of cysteine residues in glucosamine-1-phosphate acetyltransferase activity of the bifunctional GlmU protein from Escherichia coli: site-directed mutagenesis and characterization of the mutant enzymes.
Pompeo F; van Heijenoort J; Mengin-Lecreulx D
J Bacteriol; 1998 Sep; 180(18):4799-803. PubMed ID: 9733680
[TBL] [Abstract][Full Text] [Related]
34. Structure of serine acetyltransferase in complexes with CoA and its cysteine feedback inhibitor.
Olsen LR; Huang B; Vetting MW; Roderick SL
Biochemistry; 2004 May; 43(20):6013-9. PubMed ID: 15147185
[TBL] [Abstract][Full Text] [Related]
35. Identification and optimization of Escherichia coli GlmU inhibitors: an in silico approach with validation thereof.
Mehra R; Sharma R; Khan IA; Nargotra A
Eur J Med Chem; 2015 Mar; 92():78-90. PubMed ID: 25544688
[TBL] [Abstract][Full Text] [Related]
36. Crystallographic analysis of substrate binding and catalysis in dihydrolipoyl transacetylase (E2p).
Mattevi A; Obmolova G; Kalk KH; Teplyakov A; Hol WG
Biochemistry; 1993 Apr; 32(15):3887-901. PubMed ID: 8471601
[TBL] [Abstract][Full Text] [Related]
37. Purification, crystallization and preliminary X-ray data for Escherichia coli GlmU: a bifunctional acetyltransferase/uridyltransferase.
Olsen LR; Tian Y; Roderick SL
Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):296-7. PubMed ID: 11173485
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure of UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) from Mycobacterium tuberculosis.
Eniyan K; Dharavath S; Vijayan R; Bajpai U; Gourinath S
Biochim Biophys Acta Proteins Proteom; 2018 Mar; 1866(3):397-406. PubMed ID: 29203374
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of Helicobacter pylori pseudaminic acid biosynthesis N-acetyltransferase PseH: implications for substrate specificity and catalysis.
Ud-Din AI; Liu YC; Roujeinikova A
PLoS One; 2015; 10(3):e0115634. PubMed ID: 25781966
[TBL] [Abstract][Full Text] [Related]
40. Crystal structures of the archaeal UDP-GlcNAc 2-epimerase from Methanocaldococcus jannaschii reveal a conformational change induced by UDP-GlcNAc.
Chen SC; Huang CH; Yang CS; Liu JS; Kuan SM; Chen Y
Proteins; 2014 Jul; 82(7):1519-26. PubMed ID: 24470206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
